Literature DB >> 16907940

The effect of maternal methadone use on the fetal heart pattern: a computerised CTG analysis.

R Navaneethakrishnan1, S Tutty, C Sinha, S W Lindow.   

Abstract

Using a computerised analysis, the cardiotocograph (CTG) from women who use methadone (n= 25) when compared with women who do not use methadone (n= 25) showed a significant reduction in the fetal heart baseline rate, with a significant reduction in number of accelerations and episodes of high variation. The short-term variation, number of decelerations and episodes of low variation were not different between the two groups. The time taken to meet the standardised criteria was not different, and it is possible that a computer-assisted CTG analysis could be more accurate than a naked eye interpretation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16907940     DOI: 10.1111/j.1471-0528.2006.01020.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  5 in total

Review 1.  Pharmacological Management of Opioid Use Disorder in Pregnant Women.

Authors:  Christine M Wilder; Theresa Winhusen
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

2.  Fetal neurobehavioral effects of exposure to methadone or buprenorphine.

Authors:  Lauren M Jansson; Janet A Dipietro; Martha Velez; Andrea Elko; Erica Williams; Lorraine Milio; Kevin O'Grady; Hendrée E Jones
Journal:  Neurotoxicol Teratol       Date:  2010-09-22       Impact factor: 3.763

3.  Infant autonomic functioning and neonatal abstinence syndrome.

Authors:  Lauren M Jansson; Janet A Dipietro; Andrea Elko; Martha Velez
Journal:  Drug Alcohol Depend       Date:  2010-03-01       Impact factor: 4.492

Review 4.  Methadone and buprenorphine for the management of opioid dependence in pregnancy.

Authors:  Hendrée E Jones; Loretta P Finnegan; Karol Kaltenbach
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

Review 5.  A systematic review of the cardiotoxicity of methadone.

Authors:  Samira Alinejad; Toba Kazemi; Nasim Zamani; Robert S Hoffman; Omid Mehrpour
Journal:  EXCLI J       Date:  2015-05-05       Impact factor: 4.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.